Publication | Closed Access

Rational approaches of drug design for the development of selective estrogen receptor modulators (SERMs), implicated in breast cancer

Breast OncologyDrug DesignAnabolic SteroidsMedicineHormonal ReceptorRational ApproachesMechanism Of ActionBreast CancerPharmacotherapyEndocrinologyPharmacologyRadiation OncologyEndocrine-related CancerDrug DiscoveryHealth Sciences